Joseph E Palys

Array ( [id] => 3577302 [patent_doc_number] => 05580555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Regeneration of injured central nervous system axons' [patent_app_type] => 1 [patent_app_number] => 8/424604 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 2728 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580555.pdf [firstpage_image] =>[orig_patent_app_number] => 424604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732938 [patent_doc_number] => 05693752 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates' [patent_app_type] => 1 [patent_app_number] => 8/361479 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 11463 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693752.pdf [firstpage_image] =>[orig_patent_app_number] => 361479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3754713 [patent_doc_number] => 05851533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Vaccine based on membrane bound proteins and process for making them' [patent_app_type] => 1 [patent_app_number] => 8/357084 [patent_app_country] => US [patent_app_date] => 1994-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 22 [patent_no_of_words] => 17046 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851533.pdf [firstpage_image] =>[orig_patent_app_number] => 357084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979850 [patent_doc_number] => 05958678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'DNA encoding the T cell surface protein T4 and use of fragments of T4 in the treatment of AIDS' [patent_app_type] => 1 [patent_app_number] => 8/354452 [patent_app_country] => US [patent_app_date] => 1994-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 47 [patent_no_of_words] => 28120 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958678.pdf [firstpage_image] =>[orig_patent_app_number] => 354452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3643602 [patent_doc_number] => 05683701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Peptide fragments of HIV' [patent_app_type] => 1 [patent_app_number] => 8/354884 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2867 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683701.pdf [firstpage_image] =>[orig_patent_app_number] => 354884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622748 [patent_doc_number] => 05607852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Process for attenuated varicella zoster virus vaccine production' [patent_app_type] => 1 [patent_app_number] => 8/347345 [patent_app_country] => US [patent_app_date] => 1994-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12611 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607852.pdf [firstpage_image] =>[orig_patent_app_number] => 347345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3708045 [patent_doc_number] => 05654401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Borna disease virus-specific protein and kits' [patent_app_type] => 1 [patent_app_number] => 8/351176 [patent_app_country] => US [patent_app_date] => 1994-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5073 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654401.pdf [firstpage_image] =>[orig_patent_app_number] => 351176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734078 [patent_doc_number] => 05698430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Non-infective vaccines' [patent_app_type] => 1 [patent_app_number] => 8/339343 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2541 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698430.pdf [firstpage_image] =>[orig_patent_app_number] => 339343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732978 [patent_doc_number] => 05693755 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I' [patent_app_type] => 1 [patent_app_number] => 8/327129 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7437 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693755.pdf [firstpage_image] =>[orig_patent_app_number] => 327129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3882139 [patent_doc_number] => 05714152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Herpes simplex virus VP16 vaccines' [patent_app_type] => 1 [patent_app_number] => 8/322729 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13186 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714152.pdf [firstpage_image] =>[orig_patent_app_number] => 322729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3988601 [patent_doc_number] => 05891623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Diagnosis and treatment of AIDS onset' [patent_app_type] => 1 [patent_app_number] => 8/320306 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 15028 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891623.pdf [firstpage_image] =>[orig_patent_app_number] => 320306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006010 [patent_doc_number] => 05859193 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Synthetic DNA derived recombinant HIV antigens' [patent_app_type] => 1 [patent_app_number] => 8/314570 [patent_app_country] => US [patent_app_date] => 1994-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 7939 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859193.pdf [firstpage_image] =>[orig_patent_app_number] => 314570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580835 [patent_doc_number] => 05580769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'CD8.sup.+ cell antiviral factor' [patent_app_type] => 1 [patent_app_number] => 8/307179 [patent_app_country] => US [patent_app_date] => 1994-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5896 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580769.pdf [firstpage_image] =>[orig_patent_app_number] => 307179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1263346 [patent_doc_number] => 06660267 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Prevention and treatment of sepsis' [patent_app_type] => B1 [patent_app_number] => 08/304602 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 24078 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660267.pdf [firstpage_image] =>[orig_patent_app_number] => 08304602 [rel_patent_id] =>[rel_patent_doc_number] =>)